Hims Stock Catapults 126% As Obesity-Drug Wars Wage On Amid FDA ScrutinyInvestors Business Daily • 10/07/25
Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary DutiesPRNewsWire • 10/03/25
Hims & Hers Expands Health Access Through Subscription Revenue ModelZacks Investment Research • 10/03/25
Hims & Hers Health, Inc. (HIMS) Laps the Stock Market: Here's WhyZacks Investment Research • 09/29/25
HIMS vs. DOCS: Which Digital Health Platform Is a Better Investment?Zacks Investment Research • 09/26/25
Hims & Hers Expands Care Ecosystem via Global and Digital InnovationZacks Investment Research • 09/22/25
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFsBenzinga • 09/18/25
FDA Slams Hims & Hers With A Warning Letter. Investors Slam Hims Stock.Investors Business Daily • 09/16/25